THE TAPE

Septerna, Inc. Common Stock

$41.67▼ −2.18%
Last close
Relative strength
94RS
of 99, against every stock▲ +6 on the month
Powering up
Developing
+42.6%
six months against Pharmaceutical Preparations
52-week range
−21.9%
from the high
$19.69$53.34
Setup
On no screen
No base, flag or squeeze in place tonight. What is and is not there
9 days
Nov 25 · confirmed
Growth WEAKProof PENDING
Quarter to Sep 30, revenue −12% on a year ago
Why it is on no screen

SEPN passes every check below but is not on a screen — the screens also require the base to be the most recent structure, which this one is not.

A base has formed12.6 weeks, from 34.36 to 51.10.
Long enough to count12.6 weeks against 3 needed.
Shallow enough32.8% deep against 35% allowed.
Close to its pivot-18.5% from the pivot; listed down to -20%.
Relative strengthRS 94 against 70 needed.

Measured against the base-and-breakout thresholds. The other screens use their own numbers, so a name can miss here and still be a fair-looking chart.

Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
Support and resistance
Support below
$40.73
-2.3% · tested 6× · last 10 sessions ago
Resistance above
None within the last 120 sessions

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

Septerna, Inc. Common Stock is not on any of the screens right now. Its relative strength rating is 94, and it sits in Pharmaceutical Preparations.

Against its industry
DevelopingAhead of its industry over one and three months and not behind over six, in an industry at least partly aligned.
One month against its industry
+9.7%
Three months against its industry
+9.9%
Six months against its industry
+42.6%

Read against an equal-weighted index of Pharmaceutical Preparations, which is +10.9% against the S&P 500 over six months Partly aligned.

Peers
Catalyst roadmap
9
days
Earnings in 9 days
Nov 25, 2026
  1. Earningsconfirmedin 9d
    Quarterly earnings
    Nov 25, 2026
How it moves on earnings

On average 6.1% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$96.3M
-12.2% year on year
Operating margin
-76.2%
Net margin
-61.3%
Free cash flow
$-77.6M
-4.0% of market cap
Price to sales
20.2×
Price to earnings
—
not meaningful on a loss

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Nov 9
Key takeaway
Shrinking and burning cash: the quarter weakens the case.
Revenue
$18.9M
-29.4% QoQ · -12.2% YoY
Gross margin
—
Net income
−$26.6M
Loss
Free cash flow
−$13.9M
Burning · 12q runway

What the numbers say

  • Weak: Revenue -12.2% year over year, -29.4% on the quarter
  • Weak: Net loss $27M, wider than $13M last quarter
  • Weak: Burning cash: operating cash flow -$14M, free cash flow -$14M, better than -$22M last quarter · 12 quarters of cash at this burn
  • Weak: Growth externally funded: capex $127K against operating cash flow -$14M
  • Good: Net cash $167M · cash $167M
Revenue by quarter
Free cash flow
Net income
shares +2.9% in a year · net cash $167.1M

What is not obvious

  • Weak: Cash flow quality: operating cash flow -$14M included a $1M deferred-revenue inflow; -$15M without it. Customers paid ahead of delivery
  • Weak: Stock compensation $6M added back against negative operating cash flow
Final read
Growth: WEAK · Economic proof: PENDING
Key question: What turns the cash flow positive?
The next test is revenue growth: revenue -12.2% year over year, -29.4% on the quarter.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 2 of 46 tracked funds at the end of Q3 2026.

Last quarter: 2 bought new.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
GappedTape · 2026-11-13
-13.8%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
GappedTape · 2026-11-12
-7.2%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Unusual volumeTape · 2026-11-12
3.8 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
GappedTape · 2026-11-05
+9.6%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Earnings date movedEvent · 2026-11-04
2026-11-09 -> 2026-11-25
No measurable effect: stocks behave like random ones over the next three sessions (2,989 cases over 51 nights).
GappedTape · 2026-10-28
+6.7%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
GappedTape · 2026-10-21
+8.2%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Unusual volumeTape · 2026-10-08
6.6 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
2
$7,399,858 total
Sold on the open market
18
$34,822,161 total

Bought: Third Rock Ventures V, L.P.. Sold: Bhatt Elizabeth, Long Daniel D., RA CAPITAL MANAGEMENT, L.P., Shaikhly Samira.

Not counted above: 16 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-10-15 Bhatt Elizabeth · President and COOoption exercise4,000$27,240
2026-10-15 Bhatt Elizabeth · President and COOsell1,094$40,337
2026-10-15 Bhatt Elizabeth · President and COOsell2,906$109,307
2026-09-01 Long Daniel D. · SVP, Drug Discoveryoption exercise3,333$9,199
2026-09-01 Long Daniel D. · SVP, Drug Discoverysell3,333$126,078
2026-08-12 Third Rock Ventures V, L.P. · 10% ownersell147,059$7,392,656
2026-08-12 Third Rock Ventures V, L.P. · 10% ownersell141$7,202
2026-08-12 RA CAPITAL MANAGEMENT, L.P. · Director, 10% ownersell746,500$31,726,250

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What analysts expect
Strong buy1
Buy9
Hold0
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

No completed base to compare this one with yet.

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Septerna, Inc. Common Stock (SEPN) — The Tape